
|Videos|November 7, 2016
Molly Freeman on SBRT Aftercare for Patients with Lung Cancer
Author(s)Molly Freeman, CNP
Molly Freeman, CNP, discusses the aftercare that goes into treating patients with lung cancer who have undergone stereotactic body radiation therapy (SBRT).
Advertisement
Molly Freeman, CNP, from Cleveland Clinic Cancer Center, discusses the aftercare that goes into treating patients with lung cancer who have undergone stereotactic body radiation therapy (SBRT).
SBRT is a treatment option for patients with lung cancer. It is a very well-tolerated therapy with minor adverse events -- such as fatigue, chest wall aching and the low possibility of radiation pneumonitis.
Advertisement
Related Content
Advertisement




First-Line Treatment Choice and Altering Resistance in EGFR-Mutant NSCLC
Published: | Updated:

Latest CME
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses
2
Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses
3
Addressing Financial Toxicity: Team-Based Workflows in Oncology Care
4
Early Amivantamab Experience and Subcutaneous Dosing in COPERNICUS
5












































